AYTU BIOPHARMA, INC Quarterly Deferred Tax Assets, Gross in USD from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Aytu Biopharma, Inc quarterly Deferred Tax Assets, Gross history and growth rate from Q2 2015 to Q2 2024.
  • Aytu Biopharma, Inc Deferred Tax Assets, Gross for the quarter ending June 30, 2024 was $138M, a 0.5% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $138M +$680K +0.5% Jun 30, 2024 10-K 2024-09-26
Q2 2023 $137M +$4.68M +3.53% Jun 30, 2023 10-K 2024-09-26
Q2 2022 $133M +$5.25M +4.12% Jun 30, 2022 10-K 2023-10-12
Q2 2021 $127M +$86M +208% Jun 30, 2021 10-K 2022-09-27
Q2 2020 $41.4M +$18.1M +77.5% Jun 30, 2020 10-K 2021-09-28
Q2 2019 $23.3M +$6.58M +39.4% Jun 30, 2019 10-K 2020-10-06
Q2 2018 $16.7M -$2.65M -13.7% Jun 30, 2018 10-K 2019-09-26
Q2 2017 $19.4M +$8.06M +71.3% Jun 30, 2017 10-K 2018-09-06
Q2 2016 $11.3M +$7.03M +165% Jun 30, 2016 10-K 2017-08-31
Q2 2015 $4.27M Jun 30, 2015 10-K 2016-09-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.